2024
Spatiotemporal trends in COVID-19 vaccine sentiments on a social media platform and correlations with reported vaccine coverage
Zhou X, Zhang X, Larson H, de Figueiredo A, Jit M, Fodeh S, Vermund S, Zang S, Lin L, Hou Z. Spatiotemporal trends in COVID-19 vaccine sentiments on a social media platform and correlations with reported vaccine coverage. Bulletin Of The World Health Organization 2024, 102: 32-45. PMID: 38164328, PMCID: PMC10753281, DOI: 10.2471/blt.23.289682.Peer-Reviewed Original Research
2023
COVID-19 vaccine equity in Africa
Turyasingura N, James W, Vermund S. COVID-19 vaccine equity in Africa. Transactions Of The Royal Society Of Tropical Medicine And Hygiene 2023, 117: 470-472. PMID: 36622662, PMCID: PMC10235805, DOI: 10.1093/trstmh/trac130.Peer-Reviewed Original ResearchConceptsVaccine equitySevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Severe COVID-19 infectionRespiratory syndrome coronavirus 2Coronavirus disease 2019 (COVID-19) pandemicSyndrome coronavirus 2COVID-19 vaccination ratesCOVID-19 infectionDisease 2019 pandemicLower COVID-19 vaccination ratesCoronavirus 2Vaccination ratesVaccine developmentVaccine distributionGlobal health discourseHealth discourseHigh-income nationsHospitalizationInfection
2022
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
Pérez-Then E, Lucas C, Monteiro VS, Miric M, Brache V, Cochon L, Vogels CBF, Malik AA, De la Cruz E, Jorge A, De los Santos M, Leon P, Breban MI, Billig K, Yildirim I, Pearson C, Downing R, Gagnon E, Muyombwe A, Razeq J, Campbell M, Ko AI, Omer SB, Grubaugh ND, Vermund SH, Iwasaki A. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nature Medicine 2022, 28: 481-485. PMID: 35051990, PMCID: PMC8938264, DOI: 10.1038/s41591-022-01705-6.Peer-Reviewed Original ResearchConceptsTwo-dose regimenOmicron variantVaccine boosterMRNA vaccinesNeutralization activityDelta variantTwo-dose mRNA vaccinesVirus-specific antibody levelsSARS-CoV-2 Omicron variantMRNA vaccine boosterNeutralization of OmicronNumerous spike mutationsSARS-CoV-2 DeltaPotent neutralization activityInfection-induced immunityCOVID-19 vaccineBNT162b2 boosterBooster vaccinationPrime vaccinationAntibody levelsAntibody titersHumoral immunityImmune escapeInactivated vaccinesVaccine